Two Sigma Investments, LP Cabaletta Bio, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 420,477 shares of CABA stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

420,477

Previous 395,437 6.33%

Holding current value

$1.27 Million

Previous $2.96 Million 32.9%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $98,657 - $206,329	25,040 Added 6.33%	420,477 $1.98 Million
Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $2.59 Million - $6.75 Million	358,763 Added 978.25%	395,437 $2.96 Million
Q1 2024 May 15, 2024	SELL	$16.79 - $25.38 $639,984 - $967,409	-38,117 Reduced 50.96%	36,674 $625,000
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $342,685 - $655,621	28,066 Added 60.07%	74,791 $1.7 Million
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $8,690 - $13,689	734 Added 1.6%	46,725 $711,000
Q2 2023 Aug 14, 2023	SELL	$7.65 - $13.95 $295,909 - $539,599	-38,681 Reduced 45.68%	45,991 $593,000
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $498,233 - $888,094	70,372 Added 492.11%	84,672 $700,000
Q4 2022 Feb 14, 2023	SELL	$0.64 - $9.3 $15,205 - $220,949	-23,758 Reduced 62.43%	14,300 $132,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $2.05 $36,635 - $119,211	-58,152 Reduced 60.44%	38,058 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $53,181 - $113,347	-53,719 Reduced 35.83%	96,210 $102,000
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $136,688 - $318,939	81,362 Added 118.66%	149,929 $304,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $36,163 - $157,570	-10,763 Reduced 13.57%	68,567 $260,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $466,354 - $832,775	66,622 Added 524.25%	79,330 $965,000
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $151,869 - $247,420	-21,093 Reduced 62.4%	12,708 $109,000
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $178,043 - $248,986	17,136 Added 102.83%	33,801 $375,000
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $45,626 - $73,485	4,651 Added 38.71%	16,665 $208,000
Q3 2020 Nov 16, 2020	SELL	$9.71 - $14.41 $18,089 - $26,845	-1,863 Reduced 13.43%	12,014 $130,000
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $88,674 - $156,532	13,877 New	13,877 $155,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $87.9M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Cabaletta Bio, Inc. Transaction History